L. Bergougnan

发表

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

P. Rosenzweig, A. Patat, M. Canal, 2002, Human psychopharmacology.

β-Adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man

L. Bergougnan, J. Giudicelli, C. Thuillez, 2004, European Journal of Clinical Pharmacology.

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo‐Controlled, Crossover Comparison Studies

L. Bergougnan, O. Nicolas, D. Angiolillo, 2011, Clinical pharmacology and therapeutics.

First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist for endothelial protection

P. Deutsch, L. Bergougnan, Anthony J. Muslin, 2020, British journal of clinical pharmacology.

Modulation of Vasoactivity and Platelet Aggregation by Selective 5-HT Receptor Antagonism in Humans

L. Bergougnan, M. Moerland, J. Burggraaf, 2011, Journal of cardiovascular pharmacology.

Troleandomycin-triazolam interaction in healthy volunteers: Pharmacokinetic and psychometric evaluation

A. Puech, L. Bergougnan, G. Bensimon, 2004, European Journal of Clinical Pharmacology.

Alpidem: Lack of sedative effect on psychomotor performance in therapeutic doses

P. Rosenzweig, A. Patat, L. Bergougnan, 1993 .

Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial

P. Deutsch, L. Bergougnan, Anthony J. Muslin, 2020, medRxiv.

Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects

Deepak L. Bhatt, E. Vicaut, L. Bergougnan, 2011, Clinical pharmacology and therapeutics.

Modulation by external Ca2+ and nicardipine of Ca2+ influx and cytosolic concentration in human erythrocytes.

L. Bergougnan, C. Dubray, M. Devynck, 1990, Biochemical and biophysical research communications.

The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers

P. Rosenzweig, M. Canal, L. Bergougnan, 2000, Journal of psychopharmacology.